Tocilizumab for giant cell arteritis: an amazing result

Isik M., KILIÇ L., Dogan I., Calguneri M.

RHEUMATOLOGY INTERNATIONAL, cilt.33, sa.11, ss.2961-2962, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 33 Sayı: 11
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00296-012-2516-z
  • Dergi Adı: RHEUMATOLOGY INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2961-2962
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Giant cell arteritis (GCA), previously Horton's disease, is a systemic vasculitis affecting the middle-sized or large arteries in patients older than 50 years of age. The mainstay of the treatment of GCA is glucocorticoid therapy. Herein, we present a case with giant cell arteritis resistant to oral and intravenous steroid, intravenous cyclophosphamide and mycophenolate mofetil, but successfully treated with tocilizumab.